期刊
JCI INSIGHT
卷 1, 期 18, 页码 -出版社
AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/jci.insight.89278
关键词
-
资金
- NCI NIH HHS [P01 CA065493, P01 CA142106, R01 CA183559, R01 CA183560] Funding Source: Medline
- NHLBI NIH HHS [R01 HL118979] Funding Source: Medline
- NIAID NIH HHS [R01 AI034495, P01 AI056299] Funding Source: Medline
CD4(+) regulatory T cells (CD4Tregs) play a critical role in the maintenance of immune tolerance and prevention of chronic graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation. IL-2 supports the proliferation and survival of CD4Tregs and previous studies have demonstrated that IL-2 induces selective expansion of CD4Tregs and improves clinical manifestations of chronic GVHD. However, mechanisms for selective activation of CD4Tregs and the effects of low-dose IL-2 on other immune cells are not well understood. Using mass cytometry, we demonstrate that low concentrations of IL-2 selectively induce STAT5 phosphorylation in Helios(+) CD4Tregs and CD56(bright)CD16(-) NK cells in vitro. Preferential activation and expansion of Helios(+) CD4Tregs and CD56(bright)CD16(-) NK cells was also demonstrated in patients with chronic GVHD receiving low-dose IL-2. With prolonged IL-2 treatment for 48 weeks, phenotypic changes were also observed in Helios-CD4Tregs. The effects of low-dose IL-2 therapy on conventional CD4(+) T cells and CD8(+) T cells were limited to increased expression of PD-1 on effector memory T cells. These studies reveal the selective effects of low-dose IL-2 therapy on Helios(+) CD4Tregs and CD56(bright) NK cells that constitutively express high-affinity IL-2 receptors as well as the indirect effects of prolonged exposure to low concentrations of IL-2 in vivo.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据